PL3958873T3 - Kompozycja farmaceutyczna do zapobiegania nawracającemu zakażeniu dróg moczowych - Google Patents

Kompozycja farmaceutyczna do zapobiegania nawracającemu zakażeniu dróg moczowych

Info

Publication number
PL3958873T3
PL3958873T3 PL20795940.4T PL20795940T PL3958873T3 PL 3958873 T3 PL3958873 T3 PL 3958873T3 PL 20795940 T PL20795940 T PL 20795940T PL 3958873 T3 PL3958873 T3 PL 3958873T3
Authority
PL
Poland
Prior art keywords
prevention
pharmaceutical composition
urinary tract
tract infection
recurrent urinary
Prior art date
Application number
PL20795940.4T
Other languages
English (en)
Inventor
Yachun WANG
Yuching CHANG
Hsiaotien MA
Jenyau CHEN
Yuanju LEE
En Meng
Shangjen CHANG
Original Assignee
Tcm Biotech International Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tcm Biotech International Corp. filed Critical Tcm Biotech International Corp.
Publication of PL3958873T3 publication Critical patent/PL3958873T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL20795940.4T 2019-04-26 2020-04-24 Kompozycja farmaceutyczna do zapobiegania nawracającemu zakażeniu dróg moczowych PL3958873T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962838954P 2019-04-26 2019-04-26
PCT/CN2020/086737 WO2020216333A1 (en) 2019-04-26 2020-04-24 Pharmaceutical composition for prevention of recurrent urinary tract infection

Publications (1)

Publication Number Publication Date
PL3958873T3 true PL3958873T3 (pl) 2024-04-15

Family

ID=72916862

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20795940.4T PL3958873T3 (pl) 2019-04-26 2020-04-24 Kompozycja farmaceutyczna do zapobiegania nawracającemu zakażeniu dróg moczowych

Country Status (9)

Country Link
US (1) US11147832B2 (pl)
EP (1) EP3958873B1 (pl)
JP (1) JP7083968B2 (pl)
KR (1) KR102385760B1 (pl)
CN (1) CN113710254B (pl)
ES (1) ES2968164T3 (pl)
PL (1) PL3958873T3 (pl)
TW (1) TWI727770B (pl)
WO (1) WO2020216333A1 (pl)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180715A (en) * 1980-11-17 1993-01-19 The Regents Of The University Of California Irrigation of internal bladder surfaces in mammals with sodium pentosanpolysulfate
US7414039B2 (en) * 2004-01-28 2008-08-19 The Regents Of The University Of California Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
WO2008157205A2 (en) 2007-06-15 2008-12-24 Duke University Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp
CN102370989B (zh) 2010-08-19 2013-05-29 逢甲大学 治疗泌尿系统的医药组成物
JP2012116818A (ja) 2010-12-03 2012-06-21 Feng Chia Univ 泌尿器系疾患を治療する医薬組成物
GB2486713B (en) 2010-12-23 2016-06-29 Univ Feng Chia Pharmaceutical composition for treating urinary system disorders
US9132151B2 (en) 2011-01-05 2015-09-15 Feng Chia University Method for treating urinary system disorders
AU2012204311B2 (en) 2011-01-06 2017-05-04 C. Lowell Parsons Method for manufacturing composition comprising local anesthetic, heparinoid, and buffer
KR20160008496A (ko) 2013-01-28 2016-01-22 유리젠 파마슈티컬스, 인코포레이티드 헤파리노이드, 급성 작용성 마취제 및 버퍼를 포함하는 안정한 조성물
CN106456662A (zh) * 2014-02-24 2017-02-22 奥利金制药公司 口服给药的戊聚糖多硫酸盐的组合物及其使用方法
CN111511773B (zh) 2017-12-20 2023-01-13 王子控股株式会社 戊聚糖多硫酸酯以及含有戊聚糖多硫酸酯的药物

Also Published As

Publication number Publication date
EP3958873A1 (en) 2022-03-02
CN113710254A (zh) 2021-11-26
TWI727770B (zh) 2021-05-11
JP2022520895A (ja) 2022-04-01
ES2968164T3 (es) 2024-05-08
EP3958873C0 (en) 2023-11-22
KR20210126005A (ko) 2021-10-19
US20200338115A1 (en) 2020-10-29
EP3958873B1 (en) 2023-11-22
EP3958873A4 (en) 2022-06-22
JP7083968B2 (ja) 2022-06-13
WO2020216333A1 (en) 2020-10-29
KR102385760B1 (ko) 2022-04-11
TW202103712A (zh) 2021-02-01
CN113710254B (zh) 2024-03-12
US11147832B2 (en) 2021-10-19

Similar Documents

Publication Publication Date Title
EP3914252A4 (en) PHARMACEUTICAL COMPOSITION OF NILOTINIB
EP3777888A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
IL288375A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
IL279993A (en) Mannoside-C compounds are useful for treating urinary tract infections
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP3827831A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
EP3915973A4 (en) COMPOUND FOR PREPARING AN ANTIBODY-PAYLOAD CONJUGATE AND USE THEREOF
EP4098258A4 (en) PHARMACEUTICAL USE OF A CETOAMIDE COMPOUND
EP4081201A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF MANY INFLAMMATORY DISORDERS
EP4000609A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF BONE DISEASES
EP3785718A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF FLAVIVIRUS INFECTIOUS DISEASE
EP3777848A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF STROKE
EP3958873C0 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING RECURRENT URINARY TRACT INFECTION
EP3801539A4 (en) SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF LINAGLIPTIN
EP3735238A4 (en) STABLE ORAL PHARMACEUTICAL COMPOSITION OF IRON CITRATE
IL285751A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
EP4053127A4 (en) NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING CANCER
PT3911347T (pt) Composição para a sua utilização no tratamento da incontinência urinária na mulher
KR102090101B9 (ko) 구강 질환 예방 또는 치료용 조성물
EP3795155A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING A RHODANINE DERIVATIVE, FOR THE PREVENTION OR TREATMENT OF AIDS
GB202019317D0 (en) Composition for the treatment of urinary tract infections
EP3838272A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASE
IL287392A (en) New compounds and their pharmaceutical preparations for the treatment of kidney diseases
ZA202205263B (en) Solid pharmaceutical forms of perampanel
EP3950707A4 (en) COMPOSITION COMPRISING LRRD2 SLIT3 COUPLED TO ALBUMIN FOR THE PREVENTION OR TREATMENT OF A MUSCLE DISEASE